Amirhossein Sahebkar: Difference between revisions

Edit links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous edit
Content deleted Content added
VisualWikitext
Undid revision 1217738594 by Mumswiki (talk) - Titles such as Dr should not be used, added sentences are unsourced
 
(4 intermediate revisions by 4 users not shown)
Line 1: Line 1:
<!-- Please do not remove or change this AfD message until the discussion has been closed. -->
{{Article for deletion/dated|page=Amirhossein Sahebkar|timestamp=20240211191708|year=2024|month=February|day=11|substed=yes}}
<!-- Once discussion is closed, please place on talk page: {{Old AfD multi|page=Amirhossein Sahebkar|date=11 February 2024|result='''keep'''}} -->
<!-- End of AfD message, feel free to edit beyond this point -->
{{BLP sources|date=April 2022}}

{{Infobox scientist
{{Infobox scientist
| honorific_prefix =
| honorific_prefix =
| name =Amirhossein Sahebkar
| name = Amirhossein Sahebkar
| honorific_suffix =
| honorific_suffix =
| native_name = امیرحسین صاحبکار
| native_name = امیرحسین صاحبکار
Line 25: Line 19:
| resting_place_coordinates = <!--{{coord|LAT|LONG|type:landmark|display=inline,title}}-->
| resting_place_coordinates = <!--{{coord|LAT|LONG|type:landmark|display=inline,title}}-->
| other_names =
| other_names =
| siglum =
| siglum =
| pronounce =
| pronounce =
| citizenship = <!-- use only when necessary per [[WP:INFONAT]] -->
| citizenship = <!-- use only when necessary per [[WP:INFONAT]] -->
| nationality = <!-- use only when necessary per [[WP:INFONAT]] -->
| nationality = <!-- use only when necessary per [[WP:INFONAT]] -->
| fields =
| fields = Medical biotechnology, cardiovascular disease
| workplaces = [[Mashhad University of Medical Sciences]]
| workplaces = Mashhad University of Medical Sciences
| patrons =
| patrons =
| education = [[Mashhad University of Medical Sciences]] (PhD)
| education = [[Mashhad University of Medical Sciences]] (PharmD, PhD)
| alma_mater =
| alma_mater =
| thesis_title = <!--(or | thesis1_title = and | thesis2_title = )-->
| thesis_title = <!--(or | thesis1_title = and | thesis2_title = )-->
Line 50: Line 44:
| partner = <!--(or | partners = )-->
| partner = <!--(or | partners = )-->
| children =
| children =
| parents =
| parents =
| father =
| father =
| mother =
| mother =
| relatives =
| relatives =
| signature = <!--(filename only)-->
| signature = <!--(filename only)-->
| signature_alt =
| signature_alt =
Line 59: Line 53:
| footnotes =
| footnotes =
}}
}}
'''Amirhossein Sahebkar''' is an Iranian biotechnologist specializing in cardiovascular diseases. He is a faculty member in the department of medical biotechnology at the [[Mashhad University of Medical Sciences]].
'''Amirhossein Sahebkar''' is an Iranian biotechnologist and Associate Professor of Pharmaceutical Biotechnology at [[Mashhad University of Medical Sciences]] and Honorary Research Fellow at [[UWA Medical School]].<ref>{{cite web |title=Amirhossein Sahebkar |url=https://research-repository.uwa.edu.au/en/persons/amirhossein-sahebkar |website=the UWA Profiles and Research Repository |language=en}}</ref>

He is one of the top highly-cited researchers (h>100) according to [[webometrics]].<ref>{{cite web |title=Highly Cited Researchers (h>100) according to their Google Scholar Citations public profiles {{!}} Ranking Web of Universities: Webometrics ranks 30000 institutions |url=https://www.webometrics.info/en/hlargerthan100 |website=www.webometrics.info}}</ref>
== Life ==
Sahebkar completed a Pharm.D. in 2008 from [[Mashhad University of Medical Sciences]].<ref name=":0">{{Cite web |last=Sahebkar |first=Amirhossein |title=Resume |url=https://usern.tums.ac.ir/User/CV/A_sahebkar |access-date=2024-02-17 |website=[[USERN]]}}</ref> His dissertation was titled, ''An investigation of serum antibody titres to heat shock protein 27 (anti- Hsp27) as a biomarker for the detection of acute coronary syndrome''.<ref name=":0" /> Sahebkar earned a Ph.D. in pharmaceutical biotechnology from the Mashhad University of Medical Sciences. His dissertation was titled, ''Preparation and evaluation of nanoliposomes conjugated with apolipoprotein B-100 antibodies as a therapeutic option for serum LDL reduction''.<ref name=":0" /> He completed a postdoctoral fellowship in cardiometabolic diseases at the [[University of Western Australia]].<ref name=":1">{{Cite web |date=2018-02-02 |title=دانشمند برگزیده دهه اخیر کشور در علوم‌پزشکی کیست؟ |url=https://www.khabaronline.ir/news/751424/%D8%AF%D8%A7%D9%86%D8%B4%D9%85%D9%86%D8%AF-%D8%A8%D8%B1%DA%AF%D8%B2%DB%8C%D8%AF%D9%87-%D8%AF%D9%87%D9%87-%D8%A7%D8%AE%DB%8C%D8%B1-%DA%A9%D8%B4%D9%88%D8%B1-%D8%AF%D8%B1-%D8%B9%D9%84%D9%88%D9%85-%D9%BE%D8%B2%D8%B4%DA%A9%DB%8C-%DA%A9%DB%8C%D8%B3%D8%AA |access-date=2024-02-17 |website=www.khabaronline.ir |language=fa}}</ref>

Sahebkar is a faculty member in the department of medical biotechnology at the Mashhad University of Medical Sciences.<ref name=":2">{{Cite web |date=2018-02-02 |title=انتخاب دکتر صاحبکار بعنوان دانشمند برگزیده دهه اخیر در حوزه علوم پزشکی |url=https://www.isna.ir/news/96111307311/%D8%A7%D9%86%D8%AA%D8%AE%D8%A7%D8%A8-%D8%AF%DA%A9%D8%AA%D8%B1-%D8%B5%D8%A7%D8%AD%D8%A8%DA%A9%D8%A7%D8%B1-%D8%A8%D8%B9%D9%86%D9%88%D8%A7%D9%86-%D8%AF%D8%A7%D9%86%D8%B4%D9%85%D9%86%D8%AF-%D8%A8%D8%B1%DA%AF%D8%B2%DB%8C%D8%AF%D9%87-%D8%AF%D9%87%D9%87-%D8%A7%D8%AE%DB%8C%D8%B1-%D8%AF%D8%B1-%D8%AD%D9%88%D8%B2%D9%87-%D8%B9%D9%84%D9%88%D9%85 |access-date=2024-02-17 |website=ایسنا |language=fa}}</ref> His research focuses on cardiovascular disease, [[atherosclerosis]], and [[blood lipids]].<ref name=":2" /> He is a member of the [[Iran's National Elites Foundation]].<ref name=":0" /> In 2016, he was presented the Professor Dr. Fereydoun Azizi award by the [[Iranian Academy of Medical Sciences]].<ref name=":2" /><ref name=":1" />


== References ==
== References ==

Latest revision as of 17:05, 8 April 2024

Amirhossein Sahebkar
امیرحسین صاحبکار
EducationMashhad University of Medical Sciences (PharmD, PhD)
Scientific career
FieldsMedical biotechnology, cardiovascular disease
InstitutionsMashhad University of Medical Sciences

Amirhossein Sahebkar is an Iranian biotechnologist specializing in cardiovascular diseases. He is a faculty member in the department of medical biotechnology at the Mashhad University of Medical Sciences.

Life[edit]

Sahebkar completed a Pharm.D. in 2008 from Mashhad University of Medical Sciences.[1] His dissertation was titled, An investigation of serum antibody titres to heat shock protein 27 (anti- Hsp27) as a biomarker for the detection of acute coronary syndrome.[1] Sahebkar earned a Ph.D. in pharmaceutical biotechnology from the Mashhad University of Medical Sciences. His dissertation was titled, Preparation and evaluation of nanoliposomes conjugated with apolipoprotein B-100 antibodies as a therapeutic option for serum LDL reduction.[1] He completed a postdoctoral fellowship in cardiometabolic diseases at the University of Western Australia.[2]

Sahebkar is a faculty member in the department of medical biotechnology at the Mashhad University of Medical Sciences.[3] His research focuses on cardiovascular disease, atherosclerosis, and blood lipids.[3] He is a member of the Iran's National Elites Foundation.[1] In 2016, he was presented the Professor Dr. Fereydoun Azizi award by the Iranian Academy of Medical Sciences.[3][2]

References[edit]

  1. ^ a b c d Sahebkar, Amirhossein. "Resume". USERN. Retrieved 2024-02-17.
  2. ^ a b "دانشمند برگزیده دهه اخیر کشور در علوم‌پزشکی کیست؟". www.khabaronline.ir (in Persian). 2018-02-02. Retrieved 2024-02-17.
  3. ^ a b c "انتخاب دکتر صاحبکار بعنوان دانشمند برگزیده دهه اخیر در حوزه علوم پزشکی". ایسنا (in Persian). 2018-02-02. Retrieved 2024-02-17.
Stub icon 1 Stub icon 2

This Iranian academic-related biographical article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Amirhossein_Sahebkar&oldid=1217918019"